Lenalidomide Use as Part of Induction Chemotherapy Does Not Increase the Risk Of Peri-Transplant Venous Thromboembolic Events (VTE) in Patients Who Undergo Autologous Stem Cell Transplant for Multiple Myeloma

Autor:	Abhinav Deol, Ghayathri Jeyakumar, Divaya Bhutani, Asif Alavi, Voravit Ratanatharathorn, Naresh Bumma, Monica Peravali, Joseph P. Uberti, Seongho Kim, Lois Ayash
Rok vydání:	2017
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Peri Induction chemotherapy Hematology medicine.disease Surgery Internal medicine medicine In patient Stem cell business Multiple myeloma Lenalidomide medicine.drug
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 17:S328
ISSN:	2152-2650
DOI:	10.1016/j.clml.2017.07.138
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2e74c81a4c14433b79f9278954ad3165 https://doi.org/10.1016/j.clml.2017.07.138 Zobrazit plný text záznamu Full Text from ScienceDirect